Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy

Molecular and Cellular Endocrinology

Volumn 411, Issue , 2015, Pages 232-242

  Yao, Fang ^a,b   Li, Zhen ^a,c   Ehara, Takashi ^d   Yang, Lin ^b   Wang, Dandan ^a   Feng, Lulu ^a   Zhang, Yiming ^a   Wang, Kun ^a   Shi, Yonghong ^a,b   Duan, Huijun ^a,b   Zhang, Lianshan ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Network Disease of Hebei Province   (China)

^c First Hospital of Changsha City   (China)

^d MATSUMOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Diabetic nephropathy; Endoplasmic reticulum stress; Fatty acid binding protein 4; Mesangial cell

Indexed keywords

CASPASE 12; FATTY ACID BINDING PROTEIN 4; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; OLEIC ACID; PROTEIN BCL 2; SMALL INTERFERING RNA; 2-(2'-(5-ETHYL-3,4-DIPHENYL-1H-PYRAZOL-1-YL)BIPHENYL-3-YLOXY)ACETIC ACID; BIPHENYL DERIVATIVE; FABP4 PROTEIN, HUMAN; FATTY ACID; FATTY ACID BINDING PROTEIN; PYRAZOLE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; FEMALE; GLOMERULUS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY BIOPSY; LIPOTOXICITY; MALE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; KIDNEY; METABOLISM;

APOPTOSIS; BIPHENYL COMPOUNDS; CELLS, CULTURED; DIABETIC NEPHROPATHIES; ENDOPLASMIC RETICULUM STRESS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; HUMANS; KIDNEY; MALE; MESANGIAL CELLS; PYRAZOLES; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84930181000     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.05.003     Document Type: Article

References (45)

1. Baar R.A., Dingfelder C.S., Smith L.A., Bernlohr D.A., Wu C., Lange A.J., et al. Investigation of in vivo fatty acid metabolism in AFABP/aP2 (-/-). Am. J. Physiol. Endocrinol. Metab 2005, 288:E187-E193.
2. Bravo R., Parra V., Gatica D., Rodriguez A.E., Torrealba N., Paredes F., et al. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int. Rev. Cell Mol. Biol 2013, 301:215-290.
3. Busch A.K., Cordery D., Denyer G.S., Biden T.J. Expression profiling of palmitate-and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic-cell function. Diabetes 2002, 51:977-987.
4. Cabré A., Lázaro I., Girona J., Manzanares J.M., Marimón F., Plana N., et al. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J. Lipid Res 2008, 49:1746-1751.
5. Chehade J.M., Gladysz M., Mooradian A.D. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs 2013, 73:327-339.
6. Coe N.R., Bernlohr D.A. Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim. Biophys. Acta 1998, 1391:287-306.
7. Cousin S.P., Hügl S.R., Wrede C.E., Kajio H., Myers M.G., Rhodes C.J. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic β-cell line INS-1. Endocrinology 2001, 142:229-240.
8. Cunard R., Sharma K. The endoplasmic reticulum stress response and diabetic kidney disease. Am. J. Physiol. Renal Physiol 2011, 300:F1054-F1061.
9. Eizirik D.L., Miani M., Cardozo A.K. Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 2013, 56:234-241.
10. Elmasri H., Karaaslan C., Teper Y., Ghelfi E., Weng M., Ince T.A., et al. Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J. 2009, 23:3865-3873.
11. Erbay E., Babaev V.R., Mayers J.R., Makowski L., Charles K.N., Snitow M.E., et al. Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat. Med 2009, 15:1383-1391.
12. Fu Y.C., Luo N.L., Lopes-Virella M.F., Garvey W.T. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis 2002, 165:259-269.
13. Furuhashi M., Tuncman G., Görgün C.Z., Makowski L., Atsumi G., Vaillancourt E., et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 2007, 447:959-965.
14. Giacca A., Xiao C., Oprescu A.I., Carpentier A.C., Lewis G.F. Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies. Am. J. Physiol. Endocrinol. Metab 2011, 300:E255-E262.
15. Gu X., Li K., Laybutt D.R., He M.L., Zhao H.L., Chan J.C., et al. Bip overexpression, but not CHOP inhibition, attenuates fatty-acid-induced endoplasmic reticulum stress and apoptosis in HepG2 liver cells. Life Sci 2010, 87:724-732.
16. Han L.D., Xia J.F., Liang Q.L., Wang Y., Wang Y.M., Hu P., et al. Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy. Anal. Chim. Acta 2011, 689:85-91.
17. Hsu B.G., Chen Y.C., Lee R.P., Lee C.C., Lee C.J., Wang J.H. Fasting serum level of fatty acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease. Circ. J. 2010, 74:327-331.
18. Hui X., Li H., Zhou Z., Lam K.S., Xiao Y., Wu D., et al. Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J. Biol. Chem 2010, 285:10273-10280.
19. Ibrahim S.H., Kohli R., Gores G.J. Mechanisms of lipotoxicity in NAFLD and clinical implications. J. Pediatr. Gastroenterol. Nutr 2011, 53:131-140.
20. Japanese Society of Nephrology Japan Association of Renal Pathology Kidney Biopsy-Atlas and Text 2011, 85. Tokyo Medical Club, 149. second ed.
21. Karaskov E., Scott C., Zhang L., Teodoro T., Ravazzola M., Volchuk A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic β-cell apoptosis. Endocrinology 2006, 147:3398-3407.
22. Kralisch S., Fasshauer M. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?. Diabetologia 2013, 56:10-21.
23. Laybutt D.R., Preston A.M., Akerfeldt M.C., Kench J.G., Busch A.K., Biankin A.V., et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 2007, 50:752-763.
24. Liu G., Sun Y., Li Z., Song T., Wang H., Zhang Y., et al. Apoptosis induced by endoplasmic reticulum stress involved in diabetic kidney disease. Biochem. Biophys. Res. Commun 2008, 370:651-656.
25. Liu Q.Y., Quinet E., Nambi P. Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells. Mol. Cell. Biochem 2007, 302:203-213.
26. Lizicarova D., Krahulec B., Hirnerova E., Gaspar L., Celecova Z. Risk factors in diabetic nephropathy progression at present. Bratisl. Lek. Listy 2014, 115:517-521.
27. Makowski L., Boord J.B., Maeda K., Babaev V.R., Uysal K.T., Morgan M.A., et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med 2001, 7:699-705.
28. Preston A.M., Gurisik E., Bartley C., Laybutt D.R., Biden T.J. Reduced endoplasmic reticulum (ER)-to-Golgi protein trafficking contributes to ER stress in lipotoxic mouse beta cells by promoting protein overload. Diabetologia 2009, 52:2369-2373.
29. Raclot T., Langin D., Lafontan M., Groscolas R. Selective release of human adipocyte fatty acids according to molecular structure. Biochem. J. 1997, 324:911-915.
30. Raptis A.E., Viberti G. Pathogenesis of diabetic nephropathy. Exp. Clin. Endocrinol. Diabetes 2001, 109(Suppl. 2):S424-S437.
31. Rasheva V.I., Domingos P.M. Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 2009, 14:996-1007.
32. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol 2007, 8:519-529.
33. Sanchez-Niño M.D., Benito-Martin A., Ortiz A. New paradigms in cell death in human diabetic nephropathy. Kidney Int 2010, 78:737-744.
34. Scifres C.M., Chen B., Nelson D.M., Sadovsky Y. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J. Clin. Endocrinol. Metab 2011, 96:E1083-E1091.
35. Scull C.M., Tabas I. Mechanisms of ER stress-induced apoptosis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol 2011, 31:2792-2797.
36. Sieber J., Lindenmeyer M.T., Kampe K., Campbell K.N., Cohen C.D., Hopfer H., et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am. J. Physiol. Renal Physiol 2010, 299:F821-F829.
37. Soumura M., Kume S., Isshiki K., Takeda N., Araki S., Tanaka Y., et al. Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell. Biochem. Biophys. Res. Commun 2010, 402:265-271.
38. Stamenkovic I., Skalli O., Gabbiani G. Distribution of intermediate filament proteins in normal and diseased human glomeruli. Am. J. Pathol 1986, 125:465-475.
39. Szegezdi E., Logue S.E., Gorman A.M., Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006, 7:880-885.
40. Tanaka M., Furuhashi M., Okazaki Y., Mita T., Fuseya T., Ohno K., et al. Ectopic expression of fatty acid binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction. Nephron. Clin. Pract 2014, 128:345-351.
41. Tuncman G., Erbay E., Hom X., De Vivo I., Campos H., Rimm E.B., et al. A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:6970-6975.
42. von Eynatten M., Breitling L.P., Roos M., Baumann M., Rothenbacher D., Brenner H. Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease. Arterioscler. Thromb. Vasc. Biol 2012, 32:2327-2335.
43. Wang X.Q., Yang K., He Y.S., Lu L., Shen W.F. Receptor mediated elevation in FABP4 levels by advanced glycation end products induces cholesterol and triacylglycerol accumulation in THP-1 macrophages. Lipids 2011, 46:479-486.
44. Wrede C.E., Dickson L.M., Lingohr M.K., Briaud I., Rhodes C.J. Protein kinase B/akt prevents fatty acid-induced apoptosis in- pancreatic β-cells (INS-1). J. Biol. Chem 2002, 277:49676-49684.
45. Xu A., Wang Y., Xu J.Y., Stejskal D., Tam S., Zhang J., et al. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin. Chem 2006, 52:405-413.